KIDRON NADAV - Insider Non-Derivative Transactions at ORAMED PHARMACEUTICALS INC. (ORMP) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Feb 11, 2025, KIDRON NADAV's relationship to ORAMED PHARMACEUTICALS INC. (ORMP) is Director,Officer (President and CEO), and currently has 2,686,598 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ORMP insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

KIDRON NADAV - Insider Non-Derivative Transactions of ORMP Common Stock

KIDRON NADAV - Insider Non-Derivative Transactions at ORMP

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Feb 12, 2025	Acquisition -- (Common Stock)	141000	0	2400598
Feb 12, 2025	Acquisition -- (Common Stock)	186000	0	2586598
Feb 12, 2025	Acquisition -- (Common Stock)	100000	0	2686598
Jan 3, 2025	Acquisition -- (Common Stock)	433500	0	2259598
Nov 8, 2024	Acquisition -- (Common Stock)	45000	0	1826098
Jan 5, 2024	Acquisition -- (Common Stock)	329000	0	1781098
May 27, 2023	Acquisition -- (Common Stock)	120000	0	1452098
Apr 18, 2023	Acquisition -- (Common Stock)	279000	0	1332098
Mar 17, 2023	P -- (Common Stock)	26000	2.04	126000
Mar 15, 2023	P -- (Common Stock)	100000	2.01	100000